• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Res Clin Pract . Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus

tetano

Editor, Senior Moderator
Diabetes Res Clin Pract


. 2020 Jul 22;108351.
doi: 10.1016/j.diabres.2020.108351. Online ahead of print.
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus


Jing Jing Liang[SUP] 1 [/SUP], Jun Liu[SUP] 2 [/SUP], Yong Chen[SUP] 3 [/SUP], Bo Ye[SUP] 4 [/SUP], Na Li[SUP] 5 [/SUP], Xiao Wang[SUP] 6 [/SUP], Min Tang[SUP] 7 [/SUP], Jiaqing Shao[SUP] 8 [/SUP]



Affiliations

Abstract

Aims: Coronavirus disease (COVID-19), also referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is instigated by a novel coronavirus. The disease was initially reported in Wuhan, China, in December 2019. Diabetes is a risk factor associated with adverse outcomes. Herein, our objective was to investigate the characteristics of laboratory findings of type 2 diabetes mellitus (T2DM) patients infected with SARS-CoV-2.
Methods: This was a retrospective study and included 80 T2DM patients of Jinling Hospital from 2010-2020, as well as 76 COVID-19 patients without T2DM and 55 COVID-19 patients with T2DM who were treated at Huoshen hill Hospital from February 11 to March 18, 2020. We then compared the differences in laboratory test results between the three groups.
Results: The levels of lymphocytes, uric acid (UA), and globulin in the T2DM group were significantly higher. In contrast, C-reactive protein (CRP), creatinine, and lactic dehydrogenase (LDH)levels were lower than those in the COVID-19 (p < 0.05) and COVID-19 + T2DM groups (p < 0.05). No considerable difference was observed regarding the levels of alanine aminotransferase (ALT), white blood cell (WBC), aspartate aminotransferase (AST), globulin, and blood urea nitrogen (BUN) in the three groups (p>0.05).
Conclusion: T2DM patients infected with SARS-CoV-2 showed decreased levels of body mass index (BMI), lymphocytes, UA, and albumin, and increased CRP levels. The decreased BMI, UA, and albumin levels may be associated with oxidative stress response and nutritional consumption. The decreased lymphocyte counts and increased CRP levels may be related to the infection.

Keywords: COVID-19; SARS-CoV-2; T2DM; laboratory findings.
 
Back
Top Bottom